NCT00005797
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
Clinical trial condition
Anemia, Refractory
Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.
73 public trials
1 recruiting study
Anemia, Refractory trial results
NCT00309842
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00053989
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +67 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00397813
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
- Locations
-
- LDS Hospital Salt Lake City, Utah, United States
- Veterans Administration Center-Seattle Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00078858
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +220 more
- Locations
-
- Stanford University Hospitals and Clinics Stanford, California, United States
- Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT00027820
- Conditions
- Adenocarcinoma, Adult Acute Myeloid Leukemia in Remission, Anemia, +72 more
- Locations
-
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
Completed
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
NCT01012492
- Conditions
- ALL, AML, Anemia, +18 more
- Locations
-
- Boston Children's Hospital Boston, Massachusetts, United States
NCT00376480
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
- Locations
-
- Childrens Hospital Los Angeles Los Angeles, California, United States
- University of Florida Health Science Center - Gainesville Gainesville, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Children's Hospital Boston Boston, Massachusetts, United States
NCT01175785
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +38 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
NCT01165996
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +23 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States